Anticoagulant Sodium Citrate Solution Recalled for Sterility Assurance Failure
Nephron Sterile Compounding Center is recalling 85,300 pre-filled syringes of Anticoagulant Sodium Citrate Solution due to failure to assure sterility. Affected patients should contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving injectable medication with a quality control failure in sterility assurance. Although no illnesses or injuries have been reported, unsterile injectable products represent a risk-of-harm scenario that meets the High severity threshold.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling 85,300 pre-filled syringes of Anticoagulant Sodium Citrate Solution, USP 4% (40 mg/mL), distributed nationwide. The product is supplied in cartons containing 5 pre-filled syringes, with 6 cartons per case.
The recall is due to lack of assurance of sterility. The affected lots were not verified to meet sterility standards required for injectable pharmaceutical products.
Patients, healthcare providers, and facilities using the affected lot numbers (SC2002A through SC2011A, with expiration dates ranging from July 9, 2022 through October 10, 2022) should stop using the product and contact their healthcare provider or Nephron Sterile Compounding Center for instructions.
The recalled product
- Product
- Anticoagulant Sodium Citrate Solution, USP 4%, 200 mg/5 mL (40 mg/mL) syringe, packaged in 5 x 5 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-906-05
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Hazard
- sterility-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lots: SC2002A
- Exp. 7/9/2022
- SC2004A
- Exp. 7/17/2022
- SC2005A
- Exp. 8/2/2022
- SC2006A
- Exp. 8/16/2022
- SC2007A
- Exp. 8/27/2022
- SC2008A
- Exp. 9/7/2022
- SC2009A
- Exp. 9/14/2022
- SC2010A
- Exp. 9/20/2022
- SC2011A
- Exp. 10/10/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27